T. Shiosaka et al., ABNORMAL RESPONSE OF C-MYC EXPRESSION IN BONE-MARROW CELLS FROM MYELODYSPLASTIC SYNDROME PATIENTS TO PHORBOL ESTER, Journal of experimental & clinical cancer research, 13(2), 1994, pp. 125-129
The abnormal growth and differentiation of bone marrow cells from pati
ents with myelodysplastic syndrome (MDS) might be due to impairment of
signal transduction pathways leading to an abnormal response to phorb
ol ester, eg 12-0-tetradecanoylphorbol 13-acetate (TPA), receptors. Th
e impaired signal transduction pathways led to an abnormal response to
TPA, determined as the difference in the expression of c-mys before a
nd after treatment with TPA. One hour exposure to TPA did not induce c
-myc gene expression in normal bone marrow cells. In contrast, the lev
els of c-myc gene expression were increased by more than two-fold in M
DS bone marrow samples after treatment with TPA. The excess expression
of c-myc in MDS samples after exposure to TPA was inhibited by additi
on of protein kinase inhibitors (H-7, sphingosine).